4processed
Form 4 — Insider Transaction
Nurix Therapeutics, Inc.(NRIX)
Filing Date
June 25, 2026
Accepted
June 25, 2026
Accession No.
0001817199-26-000022
CIK
0001549595
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Ring Christine | Chief Legal Officer | Other | 13.3K | $7.26 | — | 26.9K | Common Stock | Jun 25, 2026 |
| Ring Christine | Chief Legal Officer | Other | 15.6K | $8.72 | — | 42.5K | Common Stock | Jun 25, 2026 |
| Ring Christine | Chief Legal Officer | Other | 28.9K | $20.062 | — | 13.6K | Common Stock | Jun 25, 2026 |
| Ring Christine | Chief Legal Officer | Other | 13.3K | $0 | — | 0 | Employee Stock Option (right to buy) | Jun 25, 2026 |
| Ring Christine | Chief Legal Officer | Other | 15.6K | $0 | — | 134.4K | Employee Stock Option (right to buy) | Jun 25, 2026 |